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Specimens of trichilemmal cyst, malignant trichilem-
moma, keratoacanthoma, and epidermal cyst were 
examined to characterize keratin peptides in hair-
follicle- derived tumors. Keratins were extracted 
from the specimens and analyzed by two-dimen-
sional gel electrophoresis and densitometry; the re-
sults were then compared with those for normal 
epidermis, the outer root sheath of hair follicles, 
psoriatic epidermis, and various nonfollicular cuta-
neous epithelial tumors. The specific nonfollicular 
tumors examined were squamous cell carcinoma, 
Bowen disease, actinic keratosis, eccrine porocarci-
noma, and sebaceous carcinoma. Immunohisto-
chemistry also was performed with a few anti-keratin 
monoclonal antibodies. As a general rule , K6 and K 16 
eratins, a type of intermediate filament, are the 
major structural proteins of various epithelial cells 
[1]. Thus far, at least 20 different keratin peptides 
(KI-K20) are known to be expressed in diverse 
human epithelia [1,2]. The expression of each ker-
atin is regulated by various factors, such as cell type, stage of 
differentiation, neoplastic change, etc. [3]. 
Several studies of the keratin peptide composition of epithelial 
skin tumors have been reported [4-10]. There have also been a few 
biologic studies of keratin in adnexal skin tumors derived from 
sweat glands [5] and hair follicles [10]. Recently, as the first in a 
series of experiments, we reported an analysis of keratin composi-
tion in sebaceous carcinomas, performed by two-dimensional gel 
electrophoresis (2-DE) [11]. Despite numerous investigations, no 
tumor-specific keratin pep tides have yet been found in epithelial 
skin tumors because of the biologic heterogeneity of such tumors. 
We have discovered, however, that in terms of the ratio of K16 to 
Kl 7, keratin expression in follicular tumors is different from that in 
nonfollicular tumors derived from other skin epithelia. In this 
study, we systematically compared the keratins of diverse epithelial 
skin tumors of different origins by performing 2- DE, densitometry, 
and immunohistochemistry. Interesting results were obtained, 
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Abbreviation: 2-DE, two-dimensional gel electrophoresis. 
were expressed in hyperproliferative conditions, such 
as epidermal tumors, and K17 was coexpressed in the 
same lesions. The ratio of K16 to K17 in many 
epithelial skin tumors has been unclear until now. 
K17 content exceeded K16 content in most follicular 
tumors, whereas in almost all the nonfollicular tu-
mors and the psoriatic epidermis, K17 levels were less 
than or about equal to K16 levels. There was a 
significant difference in the ratio of K16 to K17 
between follicular and nonfollicular skin tumors. 
These results indicate that alterations in the content 
of these keratins may be associated with follicular 
differentiation. Key words: follicular tumors/two-dimen-
sional gel electrophoresis/quantitative analysis. ] Invest Der-
matol 104:396-400, 1995 
showing larger amounts of K17 than of K16 in follicular tumors 
specifically. 
MA TERIALS AND METHODS 
Tissues Lesion-tissue samples from various epithelial skin tumors and 
psoriatic epidermis were obtained from patients admitted to our hospital. 
Controls consisted of normal epidermis from eight differen t body sites 
(excluding palm and sole epidermis) and outer root sheaths (ORS) of 15 
scalp hair follicles taken from the edge of surgical specimens. Small samples 
of unfixed material from each tumor were used for keratin extraction. A 
part of each tumor was frozen for immunohistochemistry. T he remaining 
tumor material was fixed in formalin and embedded in paraffin for histologic 
diagnosis. Hematoxylin-and-eosin-stained sections were prepared from all 
tumors, and the tumors were classified using a standard histology textbook 
[12]. The follicular and nonfollicu1.ar skin tumors used in this study are listed 
in Table I. 
The individual tumors, the lesional tissues of psoriatic epidermis, and the 
normal epidermis were prepared from tissue sections by trimming under a 
stereomicroscope to avoid contamination by surrounding connective tissue 
and/or overlying epidermis. For trichilemmal cysts and epidermal cysts, cyst 
wall epithelium was used for keratin extraction. The ORS were prepared 
from plucked anagen scalp hair follicles and separated from the hair shaft 
and bulb, in phosphate-buffered saline, under a stereomicroscope. 
Extra ctio n o f K era tins Keratin extraction was performed by the 
method of Achtstaetter et al [13]. Mir.ced tissues were washed with a 
high-salt buffer containing 1.5 M KCI, 140 mM NaCl, 0.5% Triton X - 100, 
5 mM ethylenediamine tetraacetic acid, and 10 mM Tris-HCI (PH 7.6); they 
were then sonicated and centrifuged at 4°C for 20 min (10,000 X g. three 
times). The final residues were sonicated and incubated with 100 ILl of 10M 
urea (ultrapure), 5% N onidet P-40, 5% 2-mercaptoethanol , and 2% Am-
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Table I. Quantitative Comparison of the Ratio of K16 to K17 by Densitometry in Follicular Tumors~ Nonfollicular 
Epithelial Skin Tumors~ and Psoriatic Epidermis 
Group by Ratios of K16 to K17 a 
Skin Tumors and Psoriatic Epidermis K16 < K17 b K16 ~ K17 r 
Ratio ofK14:K16:K17 
in Representative Cases 
Follicular tumors 
Trichilemmal cyst (n = 2) 
Malignant trichilemmoma (n = 2) 
Keratoacanthoma (n = 8) 
Epidermal cyst (n = 2) 
Total (n = 14)d 
Nonfollicular epithelial skin tumors 
Squamous cell carcinoma (n = 3) 
Bowen disease (n = 6) 
Actinic keratosis (n = 5) 
Eccrine porocarcinoma (n = 3) 
Sebaceous carcinomae (n = 2) 
Total (n = 191 
Nontumorous hyperproliferative epidermal disease 
Psoriatic epidermis (n = 1 O}~ 
a Numbers of cases classified into groups according to the ratio of K16 to K17 . 
b K17 exceeded K16 in quantity. 




























d versus J: p < 0.001 ci test for independence). d versus g: p < 0.001 (Fisher exact probability test). 
' The same samples were reported recently [11]. 
pholine (PH 3.5-10) for 12 h at 37°C. Mter centrifugation for 20 nun 
(10,000 X g, 30°C), the soluble supernatant was subjected to 2-DE. 
2-DE The extracted keratin was analyzed by 2-DE, using nonequilibrium 
pH gradient gel electrophoresis in the first dimension [14] and sodium 
dodecylsulfate-polyacrylamide gel electrophoresis with 12% acrylamide in 
the second dimension [15]. Gels were stained with Coomassie brilliant blue 
R-250. To identify the expressed keratin peptides, 3-phosphoglycerokinase, 
bovine serum albumin, and rabbit a-actin were employed at the same time 
as standard proteins. 
Quantitative Analysis of the Ratio of K16 to K17 The relative 
amounts of K16 and K17 to K14 in the individual tumors, psoriatic 
epidermis, and ORS were analyzed by LHB 222, Ultra Scan XL, enhanced 
laser densitometry (LKB, Bromma, Sweden). The amounts ofK16 and K17 
were estimated relative to those of K14 because K14 was usually discrete 
and was present in all samples. The relative amounts of these keratins were 
given by the density multiplied by the total area of each keratin spot stained 
with Coomassie brilliant blue. Each sample was then classified into two 
groups according to the ratio of these keratins: 1) the amounts of K17 were 
larger than those ofK16 (over 1.1 times as much as K16) (K16 < K17), and 
2) the amounts ofK16 were greater than or about equal to those ofK17 (less 
than 1.1 times as much as K16) (K16 ~ K17). Statistical analysis was 
performed by the:i test for independence and Fisher exact probability test. 
Immunohistochemistry From some representative samples of the tu-
mors, frozen sections were cut, air dried, and fixed in acetone at 4°C. After 
washing in phosphate-buffered saline, endogenous peroxidase was blocked 
by 0.001% phenylhydrazine hydrochloride at 37°C. Sections were incu-
bated overnight at 4°C with the following primary antibodies: Ks17.E3, 
specific for K17 (Progen Biotechnik GmbH, Heidelberg, Germany) [16]; 
and K8.12, specific for K13, K15, and K16 (Sigma, St. Louis, MO) [4]. 
Sections were rinsed in phosphate-buffered saline, incubated with peroxi-
dase-conjugated anti-mouse immunoglobulin rabbit serum (Dako Corp.) 
for 15 min at room temperature, and washed again in phosphate-buffered 
saline. The reactions were visualized using 3,3' -diaminobenzidine and 
H 20 2 • Sections were then washed in water, counterstained with 1 % methyl 
green, dehydrated, cleaned, and mounted. 
RESULTS 
Table I compares the ratios of K16 to K17 ill the vanous skin 
tumors and psoriatic epidermis. 
ORS Contain Similar Amounts ofK16 and K17 ~ and Normal 
Epidermis Does Not Contain These Keratins In normal 
epidermis from various body sites (i.e., the thigh, lower leg, back, 
abdomen, and forearm) , K1, KS, Ki0, Kll, and K14 were usually 
present, and K2 and K1S were sometimes found in small amounts 





Figure 1. ORS contain similar amounts of K16 and K17. and 
normal epidermis does not contain these keratins. 2-DE of keratin 
proteins in normal epidermis (46-year-old woman, thigh) (a) and ORS of 
anagen scalp hair follicles (66-year-old woman) (b). Standard proteins used: 
P, 3-phosphoglycerokinase (pI 7.4, Mr 43 kDa); B, bovine serum albumin 
(pI 6.35, Mr 68 kDa); A, rabbit a-actin (PI 5.4, Mr 42 kDa). Separation in 
the first dimension, nonequilibrium pH gradient gel electrophoresis (NE) 
(right to left); in the second dimension, sodium dodecylsulfate-polyacryl-
amide gel electrophoresis (SDS). The ratio ofK14:K16:K17 in the ORS was 
1:0.16:0.22 (6.25:1:1.38). 
the ORS of scalp hair follicles, KS, K6, K14, K16, and K17 were 
present (Fig 1b), and the ratio ofK16 to K17 was 1:1.38 (Fig 1b). 
Relative Antounts ofK17 Are Higher Than Those ofK16 in 
Hair-Follicle-Derived Tumors Trichilemmal cyst and malig-
nant trichilemmoma, both of which are widely assumed to be 
derived from hair follicle ORS [17,18], showed similar keratin 
patterns. Trichilemmal cyst exhibited intense expression (large 
amounts) ofK17 and also expressed K1, K10, and K16 (all in trace 
amounts) and KS, K6, and K14 (all in large amounts) (Fig 2a) . 
Malignant trichilemmoma contained large amounts of K17 and 
small amounts of K16 (Fig 2b). Ki, K10, and Ki1 (all in small 
amounts) and KS, K6, and K14 (all in large amounts) were also 
present in malignant trichilemmoma (Fig 2b). 
Keratoacanthoma and epidermal cyst, both of which are regarded 
as derived from follicular infundibulum [19,20], had keratin pat-
terns resembling those of trichilemmal cyst and malignant trichil-
emmoma. The keratin pattern of keratoacanthoma was character-
ized by a low level (six of eight cases) or lack (two of eight) of the 
K1 and K10 components. With respect to the ratio ofK16 to K17, 
K17 exceeded K16 in four of the eight keratoacanthomas (Fig 2c). 
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Figure 2. Relative amounts ofK17 are higher than those ofK16 in 
follicular tumors. 2-DE of keratins in trichilemmal cyst (66 -year-old 
woman, scalp) (a), malignant trichilemmoma (79-year-old woman, fore-
head) (b), keratoacanthoma (71-year-old man, nose) (c), and epidermal cyst 
(28-year-old man, right ankle) (d). The ratios of K14:K16:K17 in these 
cases were 1:0.1:1.1 (a), 1:0.16:0.53 (b), 1:0.21:0.56 (c), and 1:1.1:36 (d). 
Separation and standard proteins as in Fig 1. 
In the remaining four keratoacanthomas, K16 was higher than or 
about equal to K17. The other keratins detected in keratoacan-
thoma were KS, K6, and K14 (all in large amounts) (Fig 2d). In 
epidermal cyst, K17 largely exceeded K16 (Fig 2d). K1 and K10 
(both in trace amounts) and KS and K14 (both in large amounts) 
also were detected in epidermal cyst (Fig 2d). 
Relative Amounts ofK16 Are Higher Than or About Equal 
to Those of K17 in Nonfollicular Epithelial Skin TUlDors 
and Psoriatic Epidertnis The keratin patterns in nonfollicular 
skin tumors (squamous cell carcinoma, Bowen disease, actinic 
keratosis, eccrine porocarcinoma, and sebaceous carcinoma) and 
psoriatic epidermis were different from those in the follicular 
tumors with respect to the proportions of K16 and K17. 
Squamous cell carcinoma contained K1, K10, K16, and K17 (in 
variable amounts) and KS, K6, and K14 (all in large amounts); K16 
was greater than K17 in one of the three cases (Fig 3a). In one of 
the remaining two well-differentiated squamous cell carcinomas, 
K16 was higher than K17; in the third case, K17 was greater than 
K16. 
In all cases of Bowen disease and actinic keratosis, K16 was 
higher than or about equal to K17 (Fig 3b,c). These tumors also 
displayed K1, K10, and K11 (all in variable amounts) and KS, K6, 
and K14 (all in large amounts). 
The ratio of K16 to K17 in eccrine porocarcinoma also differed 
from that in follicular tumors. In one case of eccrine porocarci-
noma, both K16 and K17 were present in almost equally large 
amounts (Fig 3d). The other keratins found in these lesions were 
KS, K6, and K14, whereas components K1 and K10 were reduced 
(or lacking) (Fig 3d). In one of the remaining two eccrine 
porocarcinomas, both K16 and K17 were present in large amounts; 
in the third case, amounts of K17 were higher than those of K16. 
One of two sebaceous carcinomas contained both K16 and K17 
in considerable amounts, together with KS, K6, and K14, and low 
levels ofK1 and K10. The other lesion contained higher amounts of 
K16 than ofKl7, in addition to containing K1, KS, K6, KS, K10, 
K14, KlS, and Kl9 (for details, see [11]). 
Psoriatic epidermis, which was marked by hyperproliferative 
keratinocytes, had large amounts of Kl6 and K1 7, and Kl7 was 
always present in amounts less than or about equal to those ofK16 
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Figure 3. Relative amounts ofK16 are higher than or about equal 
to those ofK17 in nonfollicular epithelial skin tumors and psoriatic 
epidermis. 2-DE of keratins in squamous cell carcinoma (74 - year-old 
woman, right preauricle; moderately differentiated type) (a), Bowen disease 
(76-year-old man, left thigh) (b), actinic keratosis (76 - year-old man, right 
hand, dorsal; hypertrophic type) (c), eccrine porocarcinoma (75-year-old 
woman, left cheek) (d) , and lesional psoriatic epidermis (74-year-old man, 
back) (e). The ratios ofK14:K16:K17 in these cases were 1:0.21:0.03 (a), 
1:3.5:0.35 (b), 1:0.37:0.29 (c), 1:1.23:1.32 (d), and 1:0.28:0.13 (e). Separa-
tion and standard proteins as in Fig 1. 
(Fig 3e). K1, KS , K6, K10, K1l, and K14 also were present in 
psoriatic epidermis. 
Nonfollicular tumors and psoriatic epidermis were significantly 
different from follicular tumors in the ratio of Kl6 to Kl7 (p < 
0.001) (Table I). 
IlDlDunohistochelDistry The inner several layers of the cyst 
wall of trichilemmal cyst (the same case as shown in Fig 2a) were 
positive for Ks17.E3 (Fig 4), whereas KS.12 showed positive 
reactions only in a part of the inner two or three layers of the cyst 
Figure 4. K,,17.E3 (specific for K17) shows positive reactions in the 
large areas of the tumor cells of trichilenunal cyst. Inner several 
layers of the cyst wall reacted strongly to Ks 17 .E3. This tumor was the same 
case as shown in Fig 2a. Bar, 50 /Lm. 
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wall. The tumor cells of keratoacanthoma (one case) and squamous 
cell carcinoma ( one case), both of which showed similar amounts of 
K16 and Kl 7, were stained diffusely by Ks 17 .E3 and K8 .12. 
DISCUSSION 
It is generally agreed that K16, a partner of K6, is expressed in 
hyperproliferative epithelial cells [21]. Moreover, K17 is known to 
be induced in such conditions [22]. As shown in this study, K6, 
K16, and K17 were detected in almost all epithelial skin tumors 
examined and were also found in psoriatic epidermis, which is 
marked by nontumorous hyperproliferative keratinocytes. 
However, the main point of this investigation was the difference 
in the ratios of K16 to K17 between follicular and nonfollicular 
tumors. Our experimental results revealed the following interesting 
difference between the tumor groups. In follicular tumors, such as 
trichilemmal cyst, malignant trichilemmoma, and epidermal cyst, 
K17 was always much greater than K16. On the other hand, such 
keratin patterns were virtually absent in most nonfollicular tumors 
and in psoriatic epidermis. It follows from these results that 
relatively larger amounts ofK17 than those ofK16 were specific to 
follicular tumors, and the results thus indicate that alterations in 
these keratins are associated with follicular differentiation. 
No biochemical analyses of keratins by 2-DE have been reported 
in trichilemmal cyst or malignant trichilemmoma. An immunohis-
tochemical study of keratins in trichilemmal cyst has been reported 
[23], but the amounts of K16 and K17 were not examined. 
Assessment of the ratio ofK16 to K17 by immunohistochemistry is 
to some extent useful if proper combinations of anti-keratin 
monoclonal antibodies are used. For example, K.17.E3 (specific for 
K17) showed positive reactions in larger areas of the tumor cells of 
trichilemmal cyst than did K8.12 (specific for K13, K15, and K16) 
(Fig 4), which was consistent with the results of 2-DE and den-
sitometry. However, this method alone would not provide quan-
titative information for various types of tumors. Moreover, it is 
difficult to estimate the ratio of K16 to K17 by sodium dodecylsul-
fate-polyacrylamide gel electrophoresis alone because of the similar 
molecular weights (Mr) and isoelectric points (PI) of K16 (Mr 
48,000; pI 5.1) and K17 (Mr 46 ,000; pI 5.1) and because of the 
possible presence of proteins of similar molecular weight other than 
K16 and K17. 2-DE systems are thus more suitable for identifying 
these keratins and provide quantitative data by densitometry. 
Trichilemmal cyst and malignant trichilemmoma are regarded as 
skin tumors derived from the ORS of hair follicles [17,18]. Heid et 
al [24] reported in an immunohistochemical study of hair follicles 
that K17 was distributed distinctively in ORS. Another study [22] 
has revealed that ORS epithelium contains both K16 and K17 in 
large amounts. Our keratin analysis of ORS showed similar 
amounts ofK16 and K17 (the ratio ofK16 to K17 was 1:1.38). It 
is unclear why the ratio of K16 to K17 is different in normal ORS 
and in tumors differentiated toward ORS, i.e., trichilemmal cyst 
and malignant trichilemmoma. Such differences may be due to 
tumorous transformation, and the level of differentiation is thought 
to be different in these two epithelia. Therefore, the expression of 
K17 does not always reflect direct differentiation toward ORS. 
Keratoacanthoma and epidermal cyst are assumed to be derived 
from the infundibulum of hair follicles [19,20]. To our knowledge, 
there have been no analyses of the keratin composition in epidermal 
cyst by 2-DE. Here, we performed a keratin analysis in epidermal 
cyst and found a large increase in K17 in comparison with K16, 
consistent with the findings in trichilemmal cyst and malignant 
trichilemmoma. Moll et al [8] reported a keratin study of kerato-
acanthomas by 2-DE. In their one case, K16 was found to be 
slightly higher than K17. In our present study of keratoacanthoma, 
however, we found that K17 greatly exceeded K16 in four of eight 
cases, and K16 was higher than or almost equal to K17 in the other 
four. These inconsistent results may reflect the similarity in histo-
logic structure of keratoacanthoma and squamous cell carcinoma, 
or they may be due to differences in the growth stage of the 
keratoacanthoma. We conclude from such results that keratoacan-
thoma has characteristics of both follicular differentiation and a 
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differentiated stage that resembles squamous cell carcinoma. We 
therefore believe that follicular tumors differentiated toward ORS 
and the infundibulum of hair follicles are widely characterized by a 
predominant expression of Kl 7 . 
K16 and K17 are expressed not only in tumor lesions but also in 
various nontumorous skin conditions, such as during wound heal-
ing [21], in verruca vulgaris [8] , in condyloma acurninatum [8], and 
in psoriatic epidermis (as shown in Fig 3e). However, the level of 
K17 is usually lower than that ofK16 in such conditions; i.e. , the 
keratin patterns in these conditions are quite different from those in 
follicular tumors. We therefore conclude that a higher level ofK17 
than of K15 is a useful marker for follicular tumors. 
With respect to the expression of Kl and Kl0, we found that 
these keratins were absent in ORS and that they had decreased (or 
disappeared) in all follicular tumors. Indeed, these observations 
reveal one of the characteristics offollicular tumors. However, such 
changes also occurred in squamous cell carcinoma (Fig 3a), actinic 
keratosis (Fig 3c), eccrine porocarcinoma (Fig 3d), active lesional 
psoriatic epidermis (Fig 3e), and poorly differentiated squamous cell 
carcinoma [8,25]. Thus, the reduction or absence ofKl and Kl0 is 
not specific to follicular tumors. 
It is also of great interest that K6, a partner of K16, was always 
present in large amounts with considerable amounts ofK17, despite 
the trace amounts of K16 in trichilemmal cyst (Fig 2a) and 
epidermal cyst (Fig 2e). Therefore, pair keratins were not expressed 
in the same amounts. These findings suggest that the expression of 
abnormal amounts of individual members of keratin pairs is due to 
tumorous changes. 
Some keratin analyses have suggested that the origin of basal cell 
carcinoma is closely related to hair follicles [6,26], although views 
on the derivation of basal cell carcinoma are divergent [27-29] . The 
keratin analyses [6,26] were based on observations of specific K17 
expression. These facts are also the same to a considerable extent 
for the follicular tumors examined in this study. The prominent 
expression of K17 in human haarscheiben keratinocytes has been 
shown recently by Moll et al [30], indicating that haarscheiben are 
related to hair follicles. Thus, K17 may play an important role in 
differentiation toward hair follicles. The high ratio of K17 to K16 
also may be a suitable biologic marker for distinguishing follicular 
tumors from other epithelial skin tumors. However, future studies 
will be required to confirm this. 
There have been no general comparative studies on character-
ization of K17 in follicular and nonfollicular tumors. Here, we 
demonstrated by 2-DE, densitometry, and immunohistochemistry 
that predominant expression of Kl 7, in comparison with K16, was 
found specifically in follicular skin tumors and not in various 
nonfollicular epithelial skin tumors. 
We thank Dr. Yutaka Hoz umi for his help with the photographic work. 
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